These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 138573)

  • 21. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris.
    Borglund E; Hägermark O; Nord CE
    Scand J Infect Dis Suppl; 1984; 43():76-81. PubMed ID: 6242074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris.
    Al-Mishari MA
    Clin Ther; 1987; 9(3):273-80. PubMed ID: 2955899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical antibiotics for acne vulgaris. Current usage.
    Stoughton RB
    Arch Dermatol; 1979 Apr; 115(4):486-9. PubMed ID: 155425
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
    Eichenfield LF; Wortzman M
    Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
    Harper JC
    J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BEST study: evaluating efficacy by selected demographic subsets.
    Fernandez-Obregon A; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
    Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
    J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
    Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
    J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical tetracycline in the treatment of acne vulgaris.
    Adişen E; Kaymak Y; Gurer MA; Durukan E
    J Drugs Dermatol; 2008 Oct; 7(10):953-5. PubMed ID: 19112759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical tetracycline hydrochloride vs. topical clindamycin phosphate in the treatment of acne: a comparative study.
    Padilla RS; McCabe JM; Becker LE
    Int J Dermatol; 1981; 20(6):445-8. PubMed ID: 6455388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acne with topical antibiotics.
    Frank SB
    Postgrad Med; 1977 Jun; 61(6):92-8. PubMed ID: 141043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical clindamycin in acne: a preliminary study.
    Panzer JD; Panzer JJ
    Cutis; 1979 Jul; 24(1):118-9. PubMed ID: 157850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
    Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
    J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
    Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.